BRUSSELS, Nov 16 (Reuters) - The European Commission will
authorise on Tuesday a deal with biotech firm CureVac to secure
up to 405 million doses of its potential COVID-19 vaccine, the
head of the European Commission Ursula von der Leyen said on
Monday.
The Commission president also said she hopes to finalise a
deal soon with Moderna for its COVID-19 vaccine.
(Reporting by Francesco Guarascio @fraguarascio)